NuGene International Inc
Prices are adjusted according to historical splits.
Vitals
- Today's Low:
- $0.018
- Today's High:
- $0.025
- Open Price:
- $0.021
- 52W Low:
- $0.007
- 52W High:
- $0.17
- Prev. Close:
- $0.021
- Volume:
- 777201
Company Statistics
- Market Cap.:
- $14.35 million
- Book Value:
- 0.146
- Revenue TTM:
- $2.21 million
- Operating Margin TTM:
- -237.13%
- Gross Profit TTM:
- $-105087
- Profit Margin:
- -232.73%
- Return on Assets TTM:
- -1.68%
- Return on Equity TTM:
- -2.42%
Company Profile
NuGene International Inc had its IPO on under the ticker symbol NUGN.
The company operates in the Technology sector and Software-Application industry. NuGene International Inc has a staff strength of 11 employees.
Stock update
Shares of NuGene International Inc opened at $0.02 at the start of the last trading session i.e. 2023-09-12.
The stocks traded within a range of $0.02 - $0.03, and closed at $0.02.
This is a -10.48% slip from the previous day's closing price.
A total volume of 777,201 shares were traded at the close of the day’s session.
In the last one week, shares of NuGene International Inc have slipped by -18.26%.
NuGene International Inc's Key Ratios
NuGene International Inc has a market cap of $14.35 million, indicating a price to book ratio of 0 and a price to sales ratio of 9.6541.
In the last 12-months NuGene International Inc’s revenue was $2.21 million with a gross profit of $-105087 and an EBITDA of $-3554807. The EBITDA ratio measures NuGene International Inc's overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, NuGene International Inc’s operating margin was -237.13% while its return on assets stood at -1.68% with a return of equity of -2.42%.
In Q2, NuGene International Inc’s quarterly earnings growth was a positive 0% while revenue growth was a positive 91.6%.
NuGene International Inc’s PE and PEG Ratio
- Forward PE
- 0
- Trailing PE
- 0
- PEG
- 0
Its diluted EPS in the last 12-months stands at $-0.02 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of 0. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into NuGene International Inc’s profitability.
NuGene International Inc stock is trading at a EV to sales ratio of 29.1129 and a EV to EBITDA ratio of -1.4512. Its price to sales ratio in the trailing 12-months stood at 9.6541.
NuGene International Inc stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.
Balance sheet and cash flow metrics
- Total Assets
- $46.67 million
- Total Liabilities
- $390769.00
- Operating Cash Flow
- $0
- Capital Expenditure
- $760000
- Dividend Payout Ratio
- 0%
NuGene International Inc ended 2024 with $46.67 million in total assets and $0 in total liabilities. Its intangible assets were valued at $46.67 million while shareholder equity stood at $42.98 million.
NuGene International Inc ended 2024 with $0 in deferred long-term liabilities, $390769.00 in other current liabilities, 29490.00 in common stock, $-17423156.00 in retained earnings and $0.00 in goodwill. Its cash balance stood at $43425.00 and cash and short-term investments were $43425.00. The company’s total short-term debt was $0 while long-term debt stood at $26383.00.
NuGene International Inc’s total current assets stands at $531252.00 while long-term investments were $341470.00 and short-term investments were $0. Its net receivables were $487827.00 compared to accounts payable of $390769.00 and inventory worth $-280916.00.
In 2024, NuGene International Inc's operating cash flow was $0 while its capital expenditure stood at $760000.
Comparatively, NuGene International Inc paid $0 in dividends in 2024.
Other key metrics
- Current Trading Price
- $0.02
- 52-Week High
- $0.17
- 52-Week Low
- $0.007
- Analyst Target Price
- $
NuGene International Inc stock is currently trading at $0.02 per share. It touched a 52-week high of $0.17 and a 52-week low of $0.17. Analysts tracking the stock have a 12-month average target price of $.
Its 50-day moving average was $0.02 and 200-day moving average was $0.05 The short ratio stood at 0 indicating a short percent outstanding of 0%.
Around 517.3% of the company’s stock are held by insiders while 0% are held by institutions.
Frequently Asked Questions About NuGene International Inc
Similar Industry Stocks (Software-Application)
Most Active
Top Gainers
Top Losers
About
Livento Group, Inc. engages in the film and television production activities. The company is involved in the artificial intelligence and machine learning technology business; and real estate finance and development activities. The company was formerly known as NuGene International, Inc. and changed its name to Livento Group, Inc. in June 2022. Livento Group, Inc. is based in New York, New York.